A transformer-based strategy to develop RP20 as a potent RIPK2 inhibitor for acetaminophen-induced acute liver injury.
10.1016/j.apsb.2025.06.003
- Author:
Liang OUYANG
1
Author Information
1. Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
- Publication Type:Editorial
- Keywords:
Acute liver injury;
CMD-OPT;
Candidate;
RIPK2 inhibitors
- From:
Acta Pharmaceutica Sinica B
2025;15(7):3831-3832
- CountryChina
- Language:English
